Dup15q Syndrome Market Is Expected To Grow During The Study Period (2019-2032), DelveInsight

The Dup15q Syndrome market is expected to show positive growth, mainly attributed to the increased diagnosed prevalence and also, the launch of upcoming devices during the forecast period. Moreover, advances in disease mechanisms have yielded new diagnostic and treatment approaches, opening avenues to better treatment interventions.

The Dup15q Syndrome Market report covers emerging drugs, current treatment practices, market share of the individual therapies, and the current forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best opportunities and assess the underlying potential of the market.

Key takeaways from the Dup15q Syndrome Market Report
• As per DelveInsight analysts, total prevalent population of Dup15q syndrome in the 7MM was 46,259 in 2020.
• The estimates show highest prevalence of Dup15q syndrome in the United States with 22,245
• Dup15q syndrome is categorized into isodicentric 15 chromosome [idic (15)] and interstitial duplication 15 [int dup (15)] based on the mechanism of duplication. In 2020, out of the total diagnosed cases in the US for Dup15q syndrome, 2,917 cases and 1,945 cases were contributed by idic (15) and int dup (15), respectively.
• The leading Dup15q Syndrome Companies include Ovid Therapeutics/Takeda, and others
• The promising Dup15q Syndrome Therapies include TAK-935, Soticlestat, and others

Know which therapies are expected to grab major Dup15q Syndrome Market Share @ https://www.delveinsight.com/sample-request/dup15q-syndrome-market-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Dup15q Syndrome Overview
Dup15q syndrome is a neurogenetic disorder that results from duplications of chromosome 15q11.2-13.1. It is characterized by hypotonia, developmental delay and intellectual disability (ID), epilepsy, and autism spectrum disorder (ASD). However, the severity of developmental disabilities can vary widely depending on the type of duplication that occurred and whether it was derived maternally or paternally.

Dup15q Syndrome Epidemiology Insights
The Dup15q Syndrome epidemiology section provides insights about the historical and current Dup15q Syndrome patient pool and forecasted trends for individual seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the Dup15q Syndrome market report also provides the diagnosed patient pool and their trends along with assumptions undertaken.

Get an Exclusive Sample Copy of the Dup15q Syndrome Market Research Report Here- https://www.delveinsight.com/sample-request/dup15q-syndrome-market-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Dup15q Syndrome Market Outlook
Dup15q syndrome is characterized by hypotonia and gross and fine motor delays, variable intellectual disability (ID), autism spectrum disorder (ASD), and epilepsy, including infantile spasms. To establish the extent of disease and needs in an individual diagnosed with dup15q syndrome, a complete review of systems, a physical examination, assessments of possible feeding difficulties associated with hypotonia, neurologic examinations, including assessment for seizure activity and baseline EEG and consultation with a clinical geneticist and/or genetic counselor are recommended. Since the patient's suffering from the disease shows a variety of symptoms, and the current treatment approach helps in managing them. The choice of treatment to be adopted depends on the type of symptoms the person is showing.

Dup15q Syndrome Treatment Market
Supportive care includes occupational and physical therapy, alternative and augmentative communication, behavioral therapy (e.g., applied behavioral analysis therapy), psychotropic medications for behavioral manifestations, and standard management for seizures including medications, vagus nerve stimulators, and/diets. A patient may suffer from a specific type of seizure and later may develop other types as well. Also, the severity of these seizures varies among patient; hence the use of antiepileptic drugs varies. Commonly, the most prescribed medications are valproic acid, levetiracetam, lamotrigine, carbamazepine, zonisamide and clonazepam.

Discover more about therapy set to grab substantial Dup15q Syndrome market landscape @ https://www.delveinsight.com/report-store/dup15q-syndrome-market-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Dup15q Syndrome Market Size
The Dup15q Syndrome market size is anticipated to increase during the study period owing to the increasing incident population and rising awareness of the Dup15q Syndrome Market in the 7MM. The expected launch of emerging therapies and the research and development activities of pharmaceutical companies will also fuel the market growth during the forecast period. The market outlook section of the report helps to build a detailed comprehension of the historic, current, and forecasted Dup15q Syndrome Market size by analyzing the impact of current and emerging therapies in the market. It also provides a detailed assessment of the market drivers & barriers, unmet needs, and emerging technologies.

Dup15q Syndrome Market Drivers
• Identification of electroencephalogram (EEG) biomarker
• Support and awareness from disease advocacy groups
• Expected launch of Soticlestat (OV935/TAK935)

Dup15q Syndrome Market Barriers
• Limited understanding of the genes and biomarkers involved in dup15q syndrome
• Low awareness about the disease
• Limited epidemiological information
• Unavailability of treatment and diagnostic guidelines
• No approved therapy and weak emerging pipeline

Get to know more information about the market share of Dup15q Syndrome treatment therapies @ https://www.delveinsight.com/report-store/dup15q-syndrome-market-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Table of Content
1. Key Insights
2. Executive Summary
3. Competitive Intelligence Analysis
4. Market Overview at a Glance
5. Disease Background and Overview
6. Patient Journey
7. Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Unmet Needs
10. Key Endpoints of Dup15q Syndrome Market Treatment
11. Marketed Products
12. Emerging Therapies
13. Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Dup15q Syndrome Market Outlook
16. Access and Reimbursement Overview
17. KOL Views
18. Dup15q Syndrome Market Drivers
19. Dup15q Syndrome Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight

Company Name: DelveInsight LLP
Contact Person: Yash Bhardwaj
Email: ybhardwaj@delveinsight.com
Phone: 09193216187
Address: 304 S. Jones Blvd #2432,
City: Las Vegas
State: United States
Country: India
Website: https://www.delveinsight.com/

DelveInsight is a Business Consulting and Market research company, providing expert business solutions for the healthcare domain and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.

This release was published on openPR.